BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 19751544)

  • 1. Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.
    Valenti O; Grace AA
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):845-60. PubMed ID: 19751544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
    Skarsfeldt T
    Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Etievant A; Bétry C; Arnt J; Haddjeri N
    Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system.
    Di Matteo V; Di Giovanni G; Di Mascio M; Esposito E
    Neuropharmacology; 1999 Aug; 38(8):1195-205. PubMed ID: 10462132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.
    Valenti O; Cifelli P; Gill KM; Grace AA
    J Neurosci; 2011 Aug; 31(34):12330-8. PubMed ID: 21865475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1-D2 dopamine receptor interaction within the nucleus accumbens mediates long-loop negative feedback to the ventral tegmental area (VTA).
    Rahman S; McBride WJ
    J Neurochem; 2001 Jun; 77(5):1248-55. PubMed ID: 11389175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.
    Latagliata EC; Valzania A; Pascucci T; Campus P; Cabib S; Puglisi-Allegra S
    Psychopharmacology (Berl); 2014 Oct; 231(21):4099-108. PubMed ID: 24958228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
    Schwieler L; Erhardt S
    Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid reward and aversion effects in the posterior ventral tegmental area are mediated through dissociable opiate receptor subtypes and separate amygdalar and accumbal dopamine receptor substrates.
    Ahmad T; Laviolette SR
    Psychopharmacology (Berl); 2017 Aug; 234(15):2325-2336. PubMed ID: 28669034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
    Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
    Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons.
    Riegel AC; Zapata A; Shippenberg TS; French ED
    Neuropsychopharmacology; 2007 Jul; 32(7):1558-69. PubMed ID: 17213847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and electrophysiological evidence that 5-HT4 receptors exert a state-dependent facilitatory control in vivo on nigrostriatal, but not mesoaccumbal, dopaminergic function.
    Lucas G; Di Matteo V; De Deurwaerdère P; Porras G; Martín-Ruiz R; Artigas F; Esposito E; Spampinato U
    Eur J Neurosci; 2001 Mar; 13(5):889-98. PubMed ID: 11264661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors in the ventral tegmental area mediating nicotine-induced dopamine release in the nucleus accumbens.
    Sziráki I; Sershen H; Hashim A; Lajtha A
    Neurochem Res; 2002 Mar; 27(3):253-61. PubMed ID: 11958525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons.
    Floresco SB; Todd CL; Grace AA
    J Neurosci; 2001 Jul; 21(13):4915-22. PubMed ID: 11425919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional brain dopamine systems induced by psychotomimetic NMDA-receptor antagonists and the effects of antipsychotic drugs.
    Svensson TH
    Brain Res Brain Res Rev; 2000 Mar; 31(2-3):320-9. PubMed ID: 10719159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area.
    Rahman S; McBride WJ
    J Neurochem; 2002 Feb; 80(4):646-54. PubMed ID: 11841572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.